Clinical implications of slow sulphoxidation of thioridazine in a poor metabolizer of the debrisoquine type.
Meyer
J W
JW
Woggon
B
B
Baumann
P
P
Meyer
U A
UA
D000328:Adult; D003647:Debrisoquin / Q000378:metabolism*; D006801:Humans; D010084:Oxidation-Reduction; D011110:Polymorphism, Genetic / Q000235:genetics; D012559:Schizophrenia / Q000188:drug therapy; D013881:Thioridazine / Q000097:blood / Q000378:metabolism* / Q000627:therapeutic use
D013881:Thioridazine; D003647:Debrisoquin